In alignment with the WHO guidelines issued in 1997, the National Public Health Organization (NPHO) established a clinical and laboratory-based AFP surveillance network in March 1998 and implemented a comprehensive set of poliomyelitis surveillance measures across Greece: The NPHO conducts intensive, weekly active surveillance for AFP at the national level. The gene discussed is AFP; the disease is poliomyelitis.